392 related articles for article (PubMed ID: 26501994)
1. Microspheres and Nanotechnology for Drug Delivery.
Jóhannesson G; Stefánsson E; Loftsson T
Dev Ophthalmol; 2016; 55():93-103. PubMed ID: 26501994
[TBL] [Abstract][Full Text] [Related]
2. Nanotechnology in ocular drug delivery.
Sahoo SK; Dilnawaz F; Krishnakumar S
Drug Discov Today; 2008 Feb; 13(3-4):144-51. PubMed ID: 18275912
[TBL] [Abstract][Full Text] [Related]
3. A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.
Choonara YE; Pillay V; Danckwerts MP; Carmichael TR; du Toit LC
J Pharm Sci; 2010 May; 99(5):2219-39. PubMed ID: 19894268
[TBL] [Abstract][Full Text] [Related]
4. Nanocarriers for treatment of ocular neovascularization in the back of the eye: new vehicles for ophthalmic drug delivery.
Shen HH; Chan EC; Lee JH; Bee YS; Lin TW; Dusting GJ; Liu GS
Nanomedicine (Lond); 2015; 10(13):2093-107. PubMed ID: 26096379
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnology in ocular delivery: current and future directions.
Sultana Y; Maurya DP; Iqbal Z; Aqil M
Drugs Today (Barc); 2011 Jun; 47(6):441-55. PubMed ID: 21695286
[TBL] [Abstract][Full Text] [Related]
6. Lipid nanoparticles as drug/gene delivery systems to the retina.
del Pozo-Rodríguez A; Delgado D; Gascón AR; Solinís MÁ
J Ocul Pharmacol Ther; 2013 Mar; 29(2):173-88. PubMed ID: 23286300
[TBL] [Abstract][Full Text] [Related]
7. Recent perspectives in ocular drug delivery.
Gaudana R; Jwala J; Boddu SH; Mitra AK
Pharm Res; 2009 May; 26(5):1197-216. PubMed ID: 18758924
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in topical nano drug-delivery systems for the anterior ocular segment.
Lakhani P; Patil A; Majumdar S
Ther Deliv; 2018 Feb; 9(2):137-153. PubMed ID: 29325511
[TBL] [Abstract][Full Text] [Related]
9. Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases.
Onugwu AL; Nwagwu CS; Onugwu OS; Echezona AC; Agbo CP; Ihim SA; Emeh P; Nnamani PO; Attama AA; Khutoryanskiy VV
J Control Release; 2023 Feb; 354():465-488. PubMed ID: 36642250
[TBL] [Abstract][Full Text] [Related]
10. Pharmaceutical microscale and nanoscale approaches for efficient treatment of ocular diseases.
Bravo-Osuna I; Andrés-Guerrero V; Pastoriza Abal P; Molina-Martínez IT; Herrero-Vanrell R
Drug Deliv Transl Res; 2016 Dec; 6(6):686-707. PubMed ID: 27766598
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle-loaded biodegradable light-responsive in situ forming injectable implants for effective peptide delivery to the posterior segment of the eye.
Bisht R; Jaiswal JK; Rupenthal ID
Med Hypotheses; 2017 Jun; 103():5-9. PubMed ID: 28571808
[TBL] [Abstract][Full Text] [Related]
12. Nanocarriers in ocular drug delivery: an update review.
Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
Curr Pharm Des; 2009; 15(23):2724-50. PubMed ID: 19689343
[TBL] [Abstract][Full Text] [Related]
13. Drug delivery to the eye: what benefits do nanocarriers offer?
Joseph RR; Venkatraman SS
Nanomedicine (Lond); 2017 Mar; 12(6):683-702. PubMed ID: 28186436
[TBL] [Abstract][Full Text] [Related]
14. Application of lipid nanoparticles to ocular drug delivery.
Battaglia L; Serpe L; Foglietta F; Muntoni E; Gallarate M; Del Pozo Rodriguez A; Solinis MA
Expert Opin Drug Deliv; 2016 Dec; 13(12):1743-1757. PubMed ID: 27291069
[TBL] [Abstract][Full Text] [Related]
15. The potential of using biodegradable microspheres in retinal diseases and other intraocular pathologies.
Herrero-Vanrell R; Bravo-Osuna I; Andrés-Guerrero V; Vicario-de-la-Torre M; Molina-Martínez IT
Prog Retin Eye Res; 2014 Sep; 42():27-43. PubMed ID: 24819336
[TBL] [Abstract][Full Text] [Related]
16. Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations.
Loftsson T; Sigurdsson HH; Konrádsdóttir F; Gísladóttir S; Jansook P; Stefánsson E
Pharmazie; 2008 Mar; 63(3):171-9. PubMed ID: 18444504
[TBL] [Abstract][Full Text] [Related]
17. Theoretical and computational investigations of nanoparticle-biomembrane interactions in cellular delivery.
Ding HM; Ma YQ
Small; 2015 Mar; 11(9-10):1055-71. PubMed ID: 25387905
[TBL] [Abstract][Full Text] [Related]
18. [Drug delivery to target the posterior segment of the eye].
Behar-Cohen F
Med Sci (Paris); 2004; 20(6-7):701-6. PubMed ID: 15329823
[TBL] [Abstract][Full Text] [Related]
19. Delivery of therapeutics for deep-seated ocular conditions - status quo.
Nguyen H; Eng S; Ngo T; Dass CR
J Pharm Pharmacol; 2018 Aug; 70(8):994-1001. PubMed ID: 29675844
[TBL] [Abstract][Full Text] [Related]
20. Novel biodegradable polyesteramide microspheres for controlled drug delivery in Ophthalmology.
Andrés-Guerrero V; Zong M; Ramsay E; Rojas B; Sarkhel S; Gallego B; de Hoz R; Ramírez AI; Salazar JJ; Triviño A; Ramírez JM; Del Amo EM; Cameron N; de-Las-Heras B; Urtti A; Mihov G; Dias A; Herrero-Vanrell R
J Control Release; 2015 Aug; 211():105-17. PubMed ID: 26003040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
